PSMA-PET and PCa: an exploratory analysis beyond the numerical definition of oligometastatic state

被引:0
|
作者
Mattana, F. [1 ]
Farulla, L. Airo [1 ,2 ]
Marvaso, G. [3 ]
Corrao, G. [3 ]
Lorubbio, C. [3 ]
Vincini, M. G. [3 ]
Zaffaroni, M. [3 ]
Muraglia, L. [1 ]
Colandrea, M. [1 ]
Fodor, C. [3 ]
Ceci, F. [1 ,2 ]
Jereczek-Fossa, B. A. [2 ,3 ]
机构
[1] IEO European Inst Oncol IRCCS, Nucl Med Dept, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[3] IEO European Inst Oncol IRCCS, Dept Radiat Oncol, Milan, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0236
引用
收藏
页码:S524 / S525
页数:2
相关论文
共 50 条
  • [1] PSMA-PET and PCa: an exploratory analysis beyond the numerical definition of oligometastatic state
    Vincini, M. G.
    Corrao, G.
    Zaffaroni, M.
    Lorubbio, C.
    Mastroleo, F.
    Muraglia, L.
    Fodor, C.
    Mistretta, F. A.
    Luzzago, S.
    Musi, G.
    Marvaso, G.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1228 - S1229
  • [2] PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state
    Lorubbio, Chiara
    Marvaso, Giulia
    Corrao, Giulia
    Vincini, Maria Giulia
    Zaffaroni, Mattia
    Fodor, Cristiana
    Mattana, Francesco
    Farulla, Lighea Airo
    Colandrea, Marzia
    Ceci, Francesco
    Jereczek-Fossa, Barbara Alicja
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2479 - S2481
  • [3] Early experience with use of Stereotactic Body Radiotherapy (SBRT) for PSMA-PET detected oligometastatic Prostate Cancer (PCa)
    Ainsworth, Hannah
    BJU INTERNATIONAL, 2016, 118 : 16 - 16
  • [4] PSMA-PET GUIDED METASTASIS DIRECTED THERAPY FOR OLIGOMETASTATIC PROSTATE CANCER
    Ghaffar, Umar
    Sharma, Vidit
    Reitano, Giuseppe
    Basourakos, Spyridon P.
    Henning, Grant M.
    Ahmed, Mohamed E.
    Deol, Ekamjit S.
    Johnson, Geoffrey B.
    Andrews, Jack
    Kwon, Eugene D.
    Karnes, Robert J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1006 - E1007
  • [5] PSMA PET/CT-Guided RT in Oligometastatic PCa
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 14N - 14N
  • [6] PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer
    Deijen, C.
    Vrijenhoek, G.
    Vogel, W.
    Moonen, L.
    Pos, F.
    Van der Poel, H.
    Borst, G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S622 - S622
  • [7] PSMA-PET imaging for radiotherapy of oligometastatic recurrent prostate cancer: a survey of the DEGRO AG Stereotaxie
    Kroeze, S.
    Basler, L.
    Burger, I
    Guckenberger, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S127 - S128
  • [8] Single-center experience of PSMA-PET for individualized radiotherapy of oligometastatic recurrent prostate cancer
    Kroeze, S.
    Burger, I.
    Schueler, Garcia H.
    Hermanns, T.
    Guckenberger, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S160 - S160
  • [9] THE CHOPP STUDY: CHANGING TREATMENT PATHWAYS IN OLIGOMETASTATIC PROSTATE CANCER WITH USE OF PSMA-PET/CT
    Schmidt, Andrew
    Goh, Jeffrey
    Bhatt, Manoj
    Thomas, Paul
    Suder, Aneta
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 58 - 58
  • [10] Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
    Galgano, Samuel J.
    McDonald, Andrew M.
    West, Janelle T.
    Rais-Bahrami, Soroush
    CANCERS, 2022, 14 (14)